Skip to content

Immix Biopharma, Inc. IMMX Cash FDIC Insured Amount

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashFDICInsuredAmount.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s cash fdic insured amount.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s cash FDIC insured amount?
Immix Biopharma, Inc. (IMMX) reported cash FDIC insured amount of $250K in Q1 2026.
How has Immix Biopharma, Inc.'s cash FDIC insured amount changed year-over-year?
Immix Biopharma, Inc.'s cash FDIC insured amount decreased by 0.0% year-over-year, from $250K to $250K.
What is the long-term trend for Immix Biopharma, Inc.'s cash FDIC insured amount?
Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s cash FDIC insured amount has grown at a 0.0% compound annual growth rate (CAGR), from $250K to $250K.